{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:33:08Z","timestamp":1791822788019,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jjcc.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:32:17Z","timestamp":1708396337000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy"],"prefix":"10.1016","volume":"84","author":[{"given":"Masafumi","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ryuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2024.02.006_bb0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0010","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016352","article-title":"Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials","volume":"7","author":"Barakat","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0025","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/jce.13192","article-title":"Mortality effect of ICD in primary prevention of nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"28","author":"Luni","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/heartjnl-2016-310850","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0035","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0040","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0045","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1253\/circj.CJ-20-0637","article-title":"JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias","volume":"85","author":"Nogami","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejheart.2008.07.002","article-title":"Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis","volume":"10","author":"de Sousa","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0055","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2013.02.046","article-title":"Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (sudden cardiac death in Heart Failure Trial)","volume":"61","author":"Chen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0060","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.amjcard.2016.08.015","article-title":"Prognostic significance of nonsustained ventricular tachycardia episodes occurring early after implantable cardioverter-defibrillator implantation among patients with left ventricular dysfunction","volume":"118","author":"Jim\u00e9nez-Candil","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10840-019-00557-4","article-title":"Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy","volume":"57","author":"Zhou","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40001-020-0401-x","article-title":"Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients","volume":"25","author":"Makimoto","year":"2020","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0075","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0080","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/01.CIR.94.12.3198","article-title":"Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA investigators","volume":"94","author":"Doval","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0085","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0735-1097(98)00338-6","article-title":"Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT investigators","volume":"32","author":"Singh","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0090","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/0002-9149(84)90522-8","article-title":"Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy","volume":"53","author":"Meinertz","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/pgmj.62.728.593","article-title":"Arrhythmias in dilated cardiomyopathy","volume":"62","author":"Neri","year":"1986","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0002-9149(88)91321-5","article-title":"Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy","volume":"61","author":"Olshausen","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1253\/circj.CJ-14-0925","article-title":"Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure\u2014a report from the CHART-2 Study","volume":"79","author":"Satake","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1253\/circj.CJ-14-1394","article-title":"Prophylactic implantation of implantable cardioverter-defibrillator for Japanese patients with heart failure \u2014 problem of \u201cunderuse\u201d","volume":"79","author":"Kuga","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/eurheartj\/ehaa1057","article-title":"Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score","volume":"42","author":"Younis","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00392-019-01491-1","article-title":"Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients","volume":"109","author":"Kleemann","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.949726","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with heart failure and preserved, mildly reduced, and reduced ejection fraction: a systemic review and meta-analysis","volume":"9","author":"Wulamiding","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ehf2.13698","article-title":"Atrial appendage closure in patients with heart failure and atrial fibrillation: industry-independent single-centre study","volume":"9","author":"Saad","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186387","article-title":"Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients\u2014a systematic review and meta-analysis","volume":"12","author":"Bergau","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0155","first-page":"65","article-title":"Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death","volume":"20","author":"Amara","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2018.09.003","article-title":"Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: a propensity score-matched analysis","volume":"274","author":"Briongos-Figuero","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2018.03.017","article-title":"The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients","volume":"201","author":"Friedman","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0170","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/clc.23234","article-title":"Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy","volume":"42","author":"Kleemann","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0175","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.hroo.2021.09.009","article-title":"Sacubitril\/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction","volume":"2","author":"Fernandes","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00228-021-03189-8","article-title":"Effect of SAcubitril\/Valsartan on left ventricular ejection fraction and on the potential indication for implantable cardioverter defibrillator in primary prevention: the SAVE-ICD study","volume":"77","author":"Guerra","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jjcc.2024.02.006_bb0185","doi-asserted-by":"crossref","first-page":"oeab046","DOI":"10.1093\/ehjopen\/oeab046","article-title":"Sacubitril\/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCover-ARNI, a multicenter Italian register","volume":"2","author":"Pastore","year":"2022","journal-title":"Eur Heart J Open"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508724000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508724000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:02:00Z","timestamp":1756699320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508724000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0914508724000248"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2024.02.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}